Tsushimoto Gen | Drug Safety Research Center Tokushima Research Institute Otsuka Pharmaceutical Co. Ltd.
スポンサーリンク
概要
- TSUSHIMOTO Genの詳細を見る
- 同名の論文著者
- Drug Safety Research Center Tokushima Research Institute Otsuka Pharmaceutical Co. Ltd.の論文著者
関連著者
-
SHIBAHARA Toshikazu
Drug Safety Research Center, Tokushima Research Institute, Otsuka Pharmaceutical Co., Ltd.
-
AWOGI Takumi
Drug Safety Research Center, Tokushima Research Institute, Otsuka Pharmaceutical Co., Ltd.
-
Awogi Takumi
Department Of Toxicology Tokushima Research Institute Otsuka Pharmaceutical Co. Ltd.
-
Kaneko Etsuko
Drug Safety Research Center Tokushima Research Institute Otsuka Pharmaceutical Co. Ltd.
-
Tsushimoto Gen
Drug Safety Research Center Tokushima Research Institute Otsuka Pharmaceutical Co. Ltd.
-
Shibahara Toshikazu
Drug Safety Research Center Tokushima Research Institute Otsuka Pharmaceutical Co. Ltd.
-
Kirkland David
Hazleton Microtest
-
Ito T
Kyowa Hakko Kogyo Co. Ltd. Yamaguchi Jpn
-
Yamamoto Kyoko
Biological Science Research Institute Nomura Research Institute
-
Takahashi Nobuo
Drug Safety Research Center Tokushima Research Institute Otsuka Pharmaceutical Co. Ltd.
-
KANEKO Etsuko
Drug Safety Research Center, Tokushima Research Institute, Otsuka Pharmaceutical Co., Ltd.
-
ITOH Toshiaki
Drug Safety Research Center, Tokushima Research Institute, Otsuka Pharmaceutical Co., Ltd.
-
TSUSHIMOTO Gen
Drug Safety Research Center, Tokushima Research Institute, Otsuka Pharmaceutical Co., Ltd.
-
MARSHALL Richard
Hazleton Microtest
-
Itoh Tadanobu
Department Of Pharmacology School Of Dentistry Iwate Medical University
-
SUTOU Sizuyo
Biological Science Research Institute, Nomura Research Institute
-
SHIRAKAWA Haruko
Biological Science Research Institute, Nomura Research Institute
-
Sutou Sizuyo
Biological Science Research Institute Nomura Research Institute
-
Shirakawa Haruko
Biological Science Research Institute Nomura Research Institute
著作論文
- MUTAGENIC AND CLASTOGENIC PROPERTIES OF (3-[3-(6-BENZOYLOXY-3-CYANO-2-PYRIDYLOXYCARBONYL)BENZOYL]-1-ETHOXYMETHYL-5-FLUOROURACIL)(BOF-A2), A NEW 5-FLUOROURACIL DERIVATIVE WITH ANTI-TUMOUR ACTIVITY
- DNA-DAMAGING, MUTAGENIC, CLASTOGENIC AND CELL-CELL COMMUNICATION INHIBITORY PROPERTIES OF γ-ORYZANOL